Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009.

Slides:



Advertisements
Similar presentations
TREATMENT DATA INDICATORS IN THE UNODC DATA COLLECTION SYSTEM.
Advertisements

European Commission Justice Date | # EQUS Conference, June 2011 Building an EU Consensus for minimum quality standards in drug demand reduction -
International Telecommunication Union An Insight into BDT Programme 3 Marco Obiso ICT Applications and Cybersecurity Division Telecommunication Development.
6th EC Framework Programme for Research Scientific Support to Policies: “Integrating and Strengthening the European Research Area” Area (i) Policy-oriented.
Overview of the 2011 Work Programme Paul Griffiths Scientific committee meeting, Lisbon, November 2010.
2 emcdda.europa.eu European drug report package A comprehensive analysis on the drugs problem in Europe.
The development of an Australian drug policy index Assoc Prof Alison Ritter Director, Drug Policy Modelling Program (DPMP) University of New South Wales.
Problem drug use, HIV and injecting: an overview of the European experience Paul Griffiths, EMCDDA Drug Control in the Baltic Region, Vilnius, 27 September.
Strenghtening collaboration with Serbia - IPA4 Project expected outcomes Frédéric Denecker, Programme Management Officer Reitox and International Cooperation.
Health Aspect of Disaster Risk Assessment Dr AA Abubakar Department of Community Medicine Ahmadu Bello University Zaria Nigeria.
Comprehensive M&E Systems
Drug use, related problems and interventions targeting drug users in prison in the European countries: main issues and challenges for the future Linda.
Information needs for effective drug policy in the programme of the CZ PRES Identifying Europe’s information needs for effective drug policy Lisbon /
European Monitoring Centre for Drugs and Drug Addiction Margareta Nilson ISAJE, Helsinki, 1 September 2006.
Dr Fabienne Hariga Senior Adviser UNODC HIV Section, Vienna 27 May 2014 Mandates, missions, roles and responsibilities & relation to health in prisons.
Urban-Nexus – Integrated Urban Management David Ludlow and Michael Buser UWE Sofia November 2011.
The UK Drugs Situation: Data, information and uses Charlotte Davies, UK Focal Point Project Manager 1.
Whilst the pharmaceutical industry plays a key role in developing and producing medicines, there is a tension between industry’s need to expand product.
An EMCDDA view on recovery Roland Simon Head of Unit Intervention, Best Practice, and Scientific Partners.
Quality Assurance at the European Monitoring Centre for Drugs and Drug Addiction Sandrine Sleiman European Conference on Quality in Official Statistics,
The Open Method of Coordination in the area of Innovation Policy
HARM REDUCTION RESPONSES TO DRUGS IN THE EUROPEAN UNION – FROM MARGIN TO MAINSTREAM 8 th Annual Meeting of the European Red Cross / Red Crescent Network.
Annual report 2010: the state of the drugs problem in Europe.
Annual report 2009: the state of the drugs problem in Europe International Conference: New trends in drug use: facts and solutions, Parliament of the Republic.
Trends and developments Selected trends and some insights in prevention Vilnius, 12 November 2014 Roland Simon.
A project implemented by the HTSPE consortium This project is funded by the European Union SECURITY AND CITIZENSHIP JUSTICE
Marina Kuzman, MD, PhD Croatian National Institute of Public Health National Drug Prevention and Information System in the Republic of Croatia - impact.
An overview of European trends and developments Roland Simon ECAD Meeting 2011, Varna.
Regional Policy European Commission 1 10/17/2015 Wolfgang Petzold DG REGIO 10 September 2004 SFIT meeting on evaluation DG REGIO's Information and Communication.
European Commission Introduction to the Community Programme for Employment and Social Solidarity PROGRESS
Paul Griffiths and Roland Simon Wrap-up presentation What has the EMCDDA learned ?
How does UNODC research programme support UN inter-governmental bodies and their Member States to address the Drug Problem? DPA/RAB June 2014.
ELDD Reflection – past, present and future 29th Meeting of the Scientific Committee, 18 Nov 2008.
Overview of EMCDDA’s Scientific Work Paul Griffiths, Roland Simon – Scientific committee Meeting, February 2008.
A Strategic Research Agenda for Europe in the field of illicit drugs Priorities for socio-economic and humanities research HDG Brussels - December 10,
Linda Montanari, Buenos Aires, October 2003 CICAD/OAS, Demand Reduction Experts Group Meeting The Information System on Treatment Demand in EU EMCDDA.
Land Governance and Security of Tenure in Developing Countries White paper of the French Development cooperation LAND POLICIES AND MDGS IN RESPONSE TO.
EMCDDA Work Programme Key Issue 1: Key Indicators 30th Meeting of Scientific Committee J Vicente (together with D Olszewski, D Klempova, L Montanari,
HTA Benefits and Risks Dr Bernard Merkel European Commission.
Gerhard Bühringer, Monika Sassen Institut für Klinische Psychologie und Psychotherapie Institut für Therapieforschung, München EMCDDA work and scientific.
EMCDDA scientific publications Rosemary de Sousa, Head of Communication, 15 June 2009.
Consultant Advance Research Team. Outline UNDERSTANDING M&E DATA NEEDS PEOPLE, PARTNERSHIP AND PLANNING 1.Organizational structures with HIV M&E functions.
Peter Scherer Head, Health Division 7 th Meeting of Health Accounts Experts and Correspondents for Health Expenditure Data Paris, September 2005.
1 Vision: To be an agency producing outputs that contribute to optimal efficiency of the Indonesian Universal Health Coverage (UHC) Mission: To ensure.
Overview of EMCDDA’s 2009 Scientific Work Programme Paul Griffiths, Roland Simon - REITOX Meeting, Lisbon, November 2007.
Overview of the three-year work programme (2010–2012) Rosemary de Sousa, Roland Simon, Paul Griffiths 30th ScC meeting, June 2009.
EMCDDA Treatment data collection strategy - progress report May 09 Dagmar Hedrich, on behalf of the TWG Presentation at the meeting of the Scientific Committee,
BEST PRACTICE PORTAL BEST PRACTICE PORTAL project presentation to the Scientific Committee Ferri et al Lisbon, 16th July 2010.
National Agencies’ contribution to the evaluation of Grundtvig Action and to the National Evaluation Report on Socrates Programme Socrates - Grundtvig.
African Centre for Statistics United Nations Economic Commission for Africa Proposed Regional Medium-term Civil Registration and Vital Statistics Plan.
Monitoring and reporting on the drug phenomenon in Europe EMCDDA mandate and activities Wolfgang Götz, Scientific Committee, Palmela, 14 February 2008.
EMCDDA 2009 Conference Update Maria Moreira, November 2008.
First European conference on drug supply indicators, , Brussels – Feed-back Chloé Carpentier, Laurent Laniel, EMCDDA 33 rd meeting of the.
URBACT IMPLEMENTATION NETWORKS. URBACT in a nutshell  European Territorial Cooperation programme (ETC) co- financed by ERDF  All 28 Member States as.
Health Technology Assessment Methodology, an EUnetHTA View Basics for the Assessment in EU Countries PharmDr. Martin Visnansky, MBA, PhD., MSc. (HTA) HTA.
European network for Health Technology Assessment | JA | EUnetHTA European network for Health Technology Assessment THL Info.
Collaboration between the national EWS and treatment service providers in Hungary Anna Péterfi Hungarian National Focal Point TAIEX seminar Zagreb,
Overview of the cannabis use in Europe Paul Griffiths, Reitox academy, Berlin, 29th March 2007.
Public Health Forum Adult Substance Misuse.
DIABOLO has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No Project duration:
Vision, Mission, and Goals
Mandate of the Eurostat Working Group
Raising the bar Meeting Europe’s future challenges
Marleen De Smedt Geoffrey Thomas Cynthia Tavares
Proposed Regional Medium-term Civil Registration and Vital Statistics Plan First Conference of African Ministers Responsible for Civil Registration August.
15 June 2009 EMCDDA activities ~ Supply Reduction
Communication and publications
The new three year work programme Visions
NDPHS EXPERT GROUP ON ALCOHOL AND SUBSTANCE ABUSE (ASA EG)
Skopje, 21 November 2017, General Population Survey results– launch
Presentation transcript:

Overview of the 2010 work programme Paul Griffiths, Roland Simon, Rosemary de Sousa Scientific Committee meeting, Lisbon, November 2009

Overview Three-year strategy (2010–2012) will be implemented through three annual work plans, 2010 WP is the first Heart of the agency work remains: State-of-the-art review of the drug phenomenon Maintaining online reference point on drugs Providing ongoing support to for implementation and monitoring of the EUAP 2010 highlights: Ensuring data quality and joined analytical approaches Increase transversal work (CUPs) Establishment of EU guidelines framework and standards Improve detection and exchange on emerging trends Improve monitoring of drug supply and supply reduction activities Methodological developments (KIs, pubic expenditures, monitoring responses) Dissemination and valorisation of EMCDDA products and findings

WP schematic

Main activities

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies More efficient data processing Qualitative data in SB State of the art (AR)

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Promote tools and expert network Finalise TDI review Revise mortality cohort protocol Develop alternative estimates of PDU Finalise DRID protocol

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Polydrug use and vulnerable groups Crime and market

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools and processes Key Indicators Developmental areas Innovative strategies Treatment coverage day Drug consumption estimates Decentralised data system (data lab.) Incidence of drug use

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Implementation of EWS Emerging trends Effective implementation of Council decision Develop Forensic network Conceptualisation monitoring internet Strengthen collaboration (Europol, EMEA…)

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics of responses Set of response indicators Developmental areas Tools for non- opiates related problems Use and potential of expert ratings Environmental prevention strategies Fine-tune ST public expenditure

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics. of responses Set of response indicators Developmental areas Comprehensive model Availability, coverage of interventions Economic analysis of drug markets Better cover treatment in prison

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Availability, accessibility and characteristics. of responses Set of response indicators Developmental areas Drug policy harm indexes Alcohol-cannabis interactions Public expenditure focus on prisons Economic modelling

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools to assess drug policies Good practices, guidelines and quality standards EU guidelines for evaluation Cost of drug- related treatment Restructure ELDD 1st progress review (EUAP)

2010 work programme – main activities Monitoring the drug situation New trends and development Monitoring responses Best practices, standards and guidelines Tools to assess drug policies Good practices, guidelines and quality standards Further develop best practices portal: HR Develop and contribute to EU level guidelines and benchmarks

Cross-unit projects

2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Further develop and implement treatment data collection strategy Improve estimates of treatment coverage Improve modelling of service provision vs needs

2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Mini conference on price, purity, supply reduction activities, new trends Further deepen collaboration with EUROPOL Expert working group on DSSR Combined price purity indicator

2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Review current data collection Review and relaunch WHO prison databank

2010 work programme – Cross-unit projects Treatment DSSR Prison Modelling Audit and review approaches Develop proposal for scientific monograph

Main outputs

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Annual report Statistical bulletin

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Harm reduction: evidence, impact and challenges

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Injecting Treatment and care for older drug users Problem (meth)amphetamine use

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Drug-related infectious diseases protocol Joint manual for drug information systems EU evidence-based standards for drug prevention

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles EU’s information needs for effective drug policies Current issues for harm reduction Policy perspective on the use of internet and drug use

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles The EU cocaine market The EU ecstasy market The EU amphetamine market

2010 work programme – main outputs Ongoing improvement of emcdda.europa.eu Ongoing update of Best practice portal European legal database on drugs (ELDD) Country intervention profiles Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles

2010 work programme – main outputs Annual report package Scientific Monograph Insights Selected issues Manuals Drug profiles Drugs in focus Thematic papers Joint publications Online tools Articles Comparative analysis of HCV trends Drug-related infectious diseases modelling Polydrug use among treated clients Polydrug use among school children Monitoring drug use in prison European drug consumption Incidence of problems drug use Application of illicit drug analysis in the environment Modelling economic impact of economic recession on drug treatment Modelling disorganised crime: cannabis market

Questions and discussion…